RenovoRx, Inc.
RNXT
$0.86
-$0.03-2.89%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 136.55% | -10.53% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 136.55% | -10.53% | |||
| Cost of Revenue | 200.00% | -47.17% | |||
| Gross Profit | 128.10% | -1.41% | |||
| SG&A Expenses | 21.92% | 29.11% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 23.68% | -5.94% | |||
| Operating Income | -14.79% | 5.56% | |||
| Income Before Tax | -19.72% | -1.00% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -19.72% | -1.00% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -19.72% | -1.00% | |||
| EBIT | -14.79% | 5.56% | |||
| EBITDA | -14.80% | 5.58% | |||
| EPS Basic | -15.46% | -0.88% | |||
| Normalized Basic EPS | -39.18% | 16.30% | |||
| EPS Diluted | -15.46% | -0.88% | |||
| Normalized Diluted EPS | -39.18% | 16.30% | |||
| Average Basic Shares Outstanding | 3.75% | 0.03% | |||
| Average Diluted Shares Outstanding | 3.75% | 0.03% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||